Cargando…
Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal
Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. The Italian healthcare system is experiencing a stressful burden, especially in terms of intensive care assistance. In fact, th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230457/ https://www.ncbi.nlm.nih.gov/pubmed/32331217 http://dx.doi.org/10.3390/jcm9041191 |
_version_ | 1783534957953548288 |
---|---|
author | Radovanovic, Dejan Rizzi, Maurizio Pini, Stefano Saad, Marina Chiumello, Davide Alberto Santus, Pierachille |
author_facet | Radovanovic, Dejan Rizzi, Maurizio Pini, Stefano Saad, Marina Chiumello, Davide Alberto Santus, Pierachille |
author_sort | Radovanovic, Dejan |
collection | PubMed |
description | Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. The Italian healthcare system is experiencing a stressful burden, especially in terms of intensive care assistance. In fact, the main clinical manifestation of COVID-19 patients is represented by an acute hypoxic respiratory failure secondary to bilateral pulmonary infiltrates, that in many cases, results in an acute respiratory distress syndrome and requires an invasive ventilator support. A precocious respiratory support with non-invasive ventilation or high flow oxygen should be avoided to limit the droplets’ air-dispersion and the healthcare workers’ contamination. The application of a continuous positive airway pressure (CPAP) by means of a helmet can represent an effective alternative to recruit diseased alveolar units and improve hypoxemia. It can also limit the room contamination, improve comfort for the patients, and allow for better clinical assistance with long-term tolerability. However, the initiation of a CPAP is not free from pitfalls. It requires a careful titration and monitoring to avoid a delayed intubation. Here, we discuss the rationale and some important considerations about timing, criteria, and monitoring requirements for patients with COVID-19 respiratory failure requiring a CPAP treatment. |
format | Online Article Text |
id | pubmed-7230457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72304572020-05-22 Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal Radovanovic, Dejan Rizzi, Maurizio Pini, Stefano Saad, Marina Chiumello, Davide Alberto Santus, Pierachille J Clin Med Perspective Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. The Italian healthcare system is experiencing a stressful burden, especially in terms of intensive care assistance. In fact, the main clinical manifestation of COVID-19 patients is represented by an acute hypoxic respiratory failure secondary to bilateral pulmonary infiltrates, that in many cases, results in an acute respiratory distress syndrome and requires an invasive ventilator support. A precocious respiratory support with non-invasive ventilation or high flow oxygen should be avoided to limit the droplets’ air-dispersion and the healthcare workers’ contamination. The application of a continuous positive airway pressure (CPAP) by means of a helmet can represent an effective alternative to recruit diseased alveolar units and improve hypoxemia. It can also limit the room contamination, improve comfort for the patients, and allow for better clinical assistance with long-term tolerability. However, the initiation of a CPAP is not free from pitfalls. It requires a careful titration and monitoring to avoid a delayed intubation. Here, we discuss the rationale and some important considerations about timing, criteria, and monitoring requirements for patients with COVID-19 respiratory failure requiring a CPAP treatment. MDPI 2020-04-22 /pmc/articles/PMC7230457/ /pubmed/32331217 http://dx.doi.org/10.3390/jcm9041191 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Radovanovic, Dejan Rizzi, Maurizio Pini, Stefano Saad, Marina Chiumello, Davide Alberto Santus, Pierachille Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal |
title | Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal |
title_full | Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal |
title_fullStr | Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal |
title_full_unstemmed | Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal |
title_short | Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19: A Management Strategy Proposal |
title_sort | helmet cpap to treat acute hypoxemic respiratory failure in patients with covid-19: a management strategy proposal |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230457/ https://www.ncbi.nlm.nih.gov/pubmed/32331217 http://dx.doi.org/10.3390/jcm9041191 |
work_keys_str_mv | AT radovanovicdejan helmetcpaptotreatacutehypoxemicrespiratoryfailureinpatientswithcovid19amanagementstrategyproposal AT rizzimaurizio helmetcpaptotreatacutehypoxemicrespiratoryfailureinpatientswithcovid19amanagementstrategyproposal AT pinistefano helmetcpaptotreatacutehypoxemicrespiratoryfailureinpatientswithcovid19amanagementstrategyproposal AT saadmarina helmetcpaptotreatacutehypoxemicrespiratoryfailureinpatientswithcovid19amanagementstrategyproposal AT chiumellodavidealberto helmetcpaptotreatacutehypoxemicrespiratoryfailureinpatientswithcovid19amanagementstrategyproposal AT santuspierachille helmetcpaptotreatacutehypoxemicrespiratoryfailureinpatientswithcovid19amanagementstrategyproposal |